Member of Farmavita.net is offering dossier in European CTD format for Ranitidine; 75/150/300 mg, tablets.

Dossier is registered in the UK.

License for use of Dossier is related to initial downpayment and commitment to bulk purchase.  

Ranitidine is classified as an alimentary tract and metabolism medicine, according ATC index.

Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. 

Comments

Add New Search RSS

An Matthys  - Request further info   |Author |2009-12-30 09:28:59 Dear Madam or Sir, Your product could be of interest to our company Omega Pharma, marketing OTC medicines and personal care products in almost 40 countries. Thanks in advance. An Matthys - Project Manager Innovation Reply

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
	Please input the anti-spam code that you can read in the image.

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• Market & Patient Access (17/04/2013)
• Russian & CEE Pharma Market Access (26/03/2013)
• Real World Data 2013 (04/03/2013)

• Acetylcysteine OTC (20/08/2006)
• Cimetidine OTC (20/08/2006)
• Paracetamol OTC (20/08/2006)

• Levocetirizine (31/12/2005)
• Ginkgo biloba (18/12/2005)
• Cetirizine, oral solution (16/12/2005)